Tirzepatide

🧬 

Tirzepatide (Dual GLP-1/GIP Agonist Peptide)

Category: Metabolic & Obesity Research

Purity: ≥ 99% (Research Grade)

🔬 

Research Overview

Tirzepatide is a dual-receptor peptide analog that acts on GLP-1 and GIP receptors to enhance metabolic regulation.

It is under active investigation for its potential to promote fat loss, insulin sensitivity, and overall energy balance through appetite modulation and improved glucose utilization.

⚙️ 

Key Research Highlights

• May support significant body-fat reduction and lean-mass preservation
• Enhances glucose metabolism and insulin response in research models
• Promotes healthy lipid and cholesterol profiles
• Demonstrates potential to improve energy expenditure and satiety control
• Shows promise in ongoing studies for metabolic and cardiovascular health

⚠️ 

Disclaimer

This compound is supplied for laboratory and educational research only.

Not for human consumption, injection, or diagnostic use.